Charlotte Guzzo
Tracked across 1 events · 6 articles · First seen May 27, 2026 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Charlotte Guzzo, COO of Sano Genetics, commented on the meaningful step forward CLDI represents for undiagnosed liver disease, emphasizing its accuracy and use of existing NHS data.
May 27, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Charlotte Guzzo live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard